OLB Group, Inc. has been gaining a stellar reputation as an innovative e-commerce service provider that offers software products and services designed to help businesses sell products over the internet. Today, the young company announced they will be offering patented derma-cosmetic products from Leorex Ltd. to its clients for marketing to their end users. To coincide with the previously announced joint venture with Leorex, a new website has been launched utilizing the current platform of e-commerce from ShopFast, OLBG’s software platform, at http://www.leorexdirect.com/freetrial.aspx.

An integral part of the campaign includes free membership to the Platinum Club, which offers discounts of 25% to 45% on products that can significantly enhance a client’s overall profitability and/or competitive pricing advantage. These benefits are not only enticing to their customer base but have also started to turn the heads of investors on Wall Street.

There is a booming market for cosmetic and health-related

Fountain Healthy Aging is a pioneering firm dedicated to licensing and distributing effective, natural and safe products that slow the aging process and improve the symptoms associated with aging. Poised for rapid growth in the burgeoning anti-aging industry, the company’s main focus is on the specialty, premium product category, which provides gross margins significantly higher than the lower-priced, mainstream health products market.

The company’s relationship with its affiliates, Natural Planet USA and Atherton Health, allows the seamless integration of scientific information and expertise for the co-development of products in the healthy aging space. As a distribution company, Fountain has obtained rights to distribute products from its affiliate partners and its nutraceutical research and development subsidiary, Natural Planet USA.

Fountain’s flagship product Vitalife is a transdermally absorbed supplement that’s designed to stimulate the pituitary to release growth hormone. Clinical studies have shown a statistically significant increase in human growth hormone levels from

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, antiaging, and injury. Through their subsidiary ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. Their ProteoDERM Inc.’s anti-aging products are their Matrix NC-138 system of products. They sell the Matrix NC-138™ (3%) Serum, and a Day Cream SPF-25, Night Cream, a Gentle Cleanser, and a Gentle Exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, anti-aging, and injury. Through their subsidiary, ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. These anti-aging products are the Matrix NC-138 system of products, sold as Matrix NC-138™ (3%) Serum, Day Cream SPF-25, Matrix Night Cream, a gentle cleanser and a gentle exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell therapies a reality.

The